Associations between omega-3 fatty acids and insulin resistance and body composition in women with polycystic ovary syndrome
Open accessThe DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Abstract
Background: Polycystic ovary syndrome (PCOS) is strongly associated with abdominal obesity and insulin resistance and effective approaches to nutrition (e.g., omega-3 fatty acids intake) might improve the cardiometabolic risk profile. This study aimed to examine the associations of dietary and serum omega-3 fatty acids with insulin resistance (IR) and body composition among PCOS patients. Methods: A total of 185 patients with PCOS were included in our analysis. Dietary information was collected through face-to-face interviews using a 102-item food frequency questionnaire (FFQ). Serum omega-3 fatty acid levels were measured with the gas chromatography method. Body composition was measured by both dual-energy X-ray absorptiometry (DXA) and bioelectrical impedance (BIA) methods. The multivariable linear regression model was applied to analyze the associations of dietary and serum omega-3 fatty acids with the levels of Homeostasis Model Assessment for Insulin Resistance (HOMA-IR) and body composition parameters among PCOS patients. Results: Our results indicated that the dietary long-chain omega-3 polyunsaturated fatty acids (PUFA) intakes were negatively associated with HOMA-IR (β = –0.089, P = 0.040), fat mass (β = –0.022, P = 0.047), and body fat percentage (β = –0.026, P = 0.032). For serum biomarkers, higher total omega-3 PUFAs levels (β = –0.158, P = 0.021) and long-chain omega-3 PUFAs levels (β = –0.187, P < 0.001), particularly eicosapentaenoic acid (EPA) (β = –164, P = 0.011) and docosahexaenoic acid (DHA) (β = –0.158, P = 0.001) were also associated with decreased HOMA-IR. In addition, generally, dietary and serum long-chain omega-3 PUFA levels, DPA, and DHA levels were both positively associated with muscle mass measured by DXA; whereas serum total, long-chain and individual omega-3 PUFA levels (e.g., DPA, EPA, and DHA) were all negatively associated with fat mass and body fat percentage. These findings were further confirmed by the findings for body composition measured by the BIA method. Conclusion: Higher levels of dietary and serum omega-3 PUFAs, particularly long-chain omega PUFAs (DPA and DHA), might have beneficial effects on metabolic parameters and body composition among PCOS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Another cross-sectional study, which included 185 women with PCOS from China, found that both dietary n-3 PUFA intake as well as serum n-3 PUFA, especially EPA and DHA levels, were negatively correlated with HOMA-IR index and body fat levels [63]”
From Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome (2024) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428 · cited 3×
“An omega-3 fatty acids treatment could effectively enhance systemic insulin sensitivity in mice by up-regulating the function of G protein-coupled receptor 120 (GPR120) (19).”
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020 · cited 1×
“The etiology of PCOS is not yet clear, but genetic, environmental and lifestyle factors may contribute to its development (9, 10).”
BackgroundRojas, J., Chávez, M., Olivar, L., Rojas, M., Morillo, J., Mejías, J., Calvo, M., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/719050 · Cited by 467
Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action
Poudyal, H., Panchal, S. K., Diwan, V., & Brown, L. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.003 · Cited by 370
Omega-3 fatty acids in obesity and metabolic syndrome: A mechanistic update
Albracht-Schulte, K., Kalupahana, N. S., Ramalingam, L., Wang, S., Rahman, S. M., Robert-McComb, J., & Moustaid-Moussa, N. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.02.012 · Cited by 355
[A description on the Chinese national nutrition and health survey in 2002].
Li, L.-M., Rao, K.-Q., Kong, L., Yao, C., Hong-ding, X., Zhai, F., Ma, G., & Yang, X. (2005) · Zhonghua liuxingbingxue zazhi · Cited by 250
Lipid modulation of skeletal muscle mass and function
Lipina, C., & Hundal, H. S. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12144 · Cited by 247 · cited 1×
“The supplementation of omega-3 PUFAs might improve muscle function, including increasing protein synthesis, improving metabolic function, and suppressing atrophy in muscle cells (43).”
BackgroundNew Approach to Polycystic Ovary Syndrome and Other Forms of Anovulatory Infertility
Laven, J. S. E., Imani, B., Eijkemans, M. J. C., & Fauser, B. C. J. M. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200211000-00022 · Cited by 235 · cited 1×
“Characterized by a series of manifestations of hyperandrogenemia, persistent anovulation, and ovarian polycystic changes (1), polycystic ovary syndrome (PCOS) is one of the most common endocrine-metabolic disorders that affects 5 to 10% of women of reproductive age (2).”
Background
Research works printed but not linked: 1
- 16. Salek M Clark CCT Taghizadeh M. Jafarnejad S. N-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications. EXCLI J. (2019) 18: 558– 75. 31611740 10.17179/excli2019-1534 PMC6785778 · doi:10.17179/excli2019-1534 · Paper page
Cited by
n-3 PUFA Promotes Ferroptosis in PCOS GCs by Inhibiting YAP1 through Activation of the Hippo Pathway
Zhang, P., Pan, Y., Wu, S., He, Y., Wang, J., Chen, L., Zhang, S., Zhang, H., Zhao, Y., Niu, L., et al. (2023) · Nutrients · doi:10.3390/nu15081927 · Cited by 35
Therapeutic Potential of Olive Leaf Extracts: A Comprehensive Review
de Oliveira, N. M., Machado, J. P., Chéu, M. H., Lopes, L. T., & Criado, M. B. (2024) · Applied Biosciences · doi:10.3390/applbiosci3030026 · Cited by 43
“[245] and (3) improved pregnancy rate in inducted-ovulation PCOS women [247].”
Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome
Albardan, L., Platat, C., & Kalupahana, N. S. (2024) · Nutrients · doi:10.3390/nu16172961 · Cited by 18
“…included 185 women with PCOS from China, found that both dietary n -3 PUFA intake as well as serum n -3 PUFA, especially EPA and DHA levels, were negatively correlated with HOMA-IR index and body fat levels [63], suggesting that n -3 PUFA may help in improving insulin resistance among these women.”
BackgroundShao, F., Xu, S., Zhao, H., Zhang, F., Wang, X., & Wang, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1420004 · Cited by 8
Fisberg, M., Batista, L. D., Previdelli, Á. N., Ferrari, G., & Fisberg, R. M. (2024) · Nutrients · doi:10.3390/nu16050750 · Cited by 10
“Lu et al. [45] investigated omega-3 fatty acids in the body composition of women with polycystic ovary syndrome and found a mean intake of EPA and DHA of 19.8 mg/day and 18.1 mg/day, respectively.”
BackgroundInfluentialElvina, L., Chen, C., Nguyen, D. H. N., Wei, C.-C., Su, C., Fang, T., Sutanto, F., & Li, S. (2025) · Nutrients · doi:10.3390/nu17233656 · Cited by 10
Sousa, S., Pestana, D., Faria, G. R., Delerue-Matos, C. M., Calhau, C., & Domingues, V. F. (2023) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2023.102581 · Cited by 7
The PCOS puzzle: putting the pieces together for optimal care
Dar, M. A., Maqbool, M., & Ara, I. (2023) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2023-0102 · Cited by 7
Zhang, Y., Shi, B., Tian, Y., XU, S., & Chang, H. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1697275 · Cited by 11
“Higher levels of both EPA and DHA were individually associated with lowered HOMA-IR, while dietary and serum ω -3 PUFAs showed a positive correlation with muscle mass and negative correlations with fat mass and body fat percentage (158).”
Natural Chemical Constituents and Polymer Used in to Reduce PCOS Pain
Sarwade, P. P., Dhanasree, B., Gaisamudre, K. N., Kumar, R., Banerjee, A., Dubey, S. A., Otia, M. K., & Kumar, V. (2025) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.4.1.10 · Cited by 5
Essential fatty acid and analysis of their impact on the human body based on latest research
Taborska, N., Martyka, A., Kubicka-Figiel, M., & Ujma, P. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.51.013 · Cited by 3
Delanerolle, G., Ayis, S. A., Barzilova, V., Phiri, P., Jagadeesan, P., Zeng, Y., Ranaweera, S., Shetty, A., Haque, N., Kar, D., et al. (2025) · Academia Mental Health and Well-Being · doi:10.20935/mhealthwellb7404 · Cited by 3
Zhang, J., Li, H., Deng, Q., Huang, A. M., Qiu, W., Wang, L., Xiang, Z., Yang, R., Liang, J., & Liu, Z. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02267-4 · Cited by 3
Omega-3 fatty acids improve lipid metabolism by regulating miR-34a
Li, L., Tang, Y., Wang, X., Wang, C., & Song, G. (2026) · Scientific Reports · doi:10.1038/s41598-026-43353-7 · Cited by 1
“Moreover, the reduction in serum insulin and the increase in QUICKI values suggest that omega-3 fatty acids may possess insulin-sensitizing properties, consistent with previous studies 18,19 .”
Zarezadeh, R., Fattahi, A., Hamdi, K., Nouri, M., & Darabi, M. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02151-5 · Cited by 1
“In partial agreement, attenuation in EPA-and DHA-containing lipid classes, such as ether lipids and plasmalogens, was found to be associated with exacerbated insulin resistance and androgen excess [60, 61], as well as with greater susceptibility to pregnancy loss [62] in women with PCOS.”
Victorino, K. G. G., Ariza‐Ortega, J. A., & Delgado‐Olivares, L. (2025) · South Florida Journal of Development · doi:10.46932/sfjdv6n3-028
Nessa, A., Akter, S., Hossain, F., Alam, H., Sultana, R., Islam, M. A., Tarique, M. M. A., & Banu, J. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20251971
Huang, L., Li, H., Zhao, M., Wang, X., Zhang, Y., Ba, L., Yin, J., Wang, B., Zhang, X., & Hong, X. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70437
Singnale, P., Sasmal, D., Chukkala, S. S., Chilumula, M., Raghavendra, P., Singh, S. P., Mummadi, M. K., & Gondru, R. (2026) · Cureus · doi:10.7759/cureus.106497
“Some studies also demonstrate that long‑chain omega‑3 PUFAs are negatively correlated with HOMA‑IR and body fat measures in PCOS patients, emphasizing their beneficial effects on body composition and overall metabolic function [35].”
Wang, C., Yu, J., Zhai, J., Wu, Y., Wang, Y., Chen, Z., & Du, Y. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1797101 · Cited by 1
Gao, Y., Liu, C., & He, X. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1840605
“Lu L (Lu et al., 2022a) found that total dietary omega-3 polyunsaturated fatty acids and their subtypes (EPA and DHA) long-chain omega-3 polyunsaturated fatty acids were signi fi cantly negatively correlated with HOMA-IR, alleviating IR by regulating the silent information regulator 1 (SIRT1)…”
Ramaiah, P., Nomani, I., Asfour, H. I., Kodirov, G., Rajalingam, B., Yusupaliyeva, G., Agarwal, S., Rab, S. O., Thukaral, B., & Almohamadi, H. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1986758
Metadata
- Authors
- Lu, L., Li, X., Lv, L., Xu, Y., Wu, B., & Huang, C.
- Affiliations
- First Affiliated Hospital of Chengdu Medical College (CN)
- Guangdong Provincial People's Hospital (CN)
- Corresponding author
- Lu, Ling
- Venue
- Frontiers in Nutrition
- Publisher
- Frontiers Media SA
- Published
- 2022-10-05
- Volume
- 9
- Pages
- 1016943-1016943
- ISSN
- 2296-861X (ISSN-L)
- PMC
- PMC9581053
- OpenAlex
- W4301394269
- Cited by
- 22
- References
- 45
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 6 · 2023: 3
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Update notices
- corrigendum (2024-03-01)
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Nutrition (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Natural Science Foundation of Xinjiang
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- polycystic ovary syndrome, omega-3 fatty acids, long-chain polyunsaturated fatty acids, insulin resistance, HOMA-IR, body composition, fat mass, muscle mass, eicosapentaenoic acid, docosahexaenoic acid, dietary intake, serum biomarkers, women's health, cardiometabolic risk, abdominal obesity, DPA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.